SRC and neoplasm: Meanwhile,c-Src can positively regulate LIST transcription by activating the NF-κB signaling pathway and recruiting the P65 transcription factor into the LIST promoter, thus forming a positive feedback pathway between LIST and c-Src that further promote tumor progression and drug resistance [63].